BioSpace News Archive

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases, announced the results of the voting by shareholders at the Combined Shareholders Meeting which took place on June 30, 2021 behind closed doors at the Company’s headquarters.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2021 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Thursday, July 29.

McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2022 financial results after market close on Wednesday, August 4, 2021.

Tenaya Therapeutics, a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced the hires of Leone Patterson, MBA, as Chief Financial and Business Officer and Matthew Pollman, MD, MS, as Senior Vice President, Clinical Development.

CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced results from the final analysis of its 40,000 subject international pivotal Phase 2b/3 study (the HERALD study) of the first-generation COVID-19 vaccine candidate, CVnCoV.

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the third quarter of fiscal year 2021 on Thursday, August 5, 2021. BD will issue a press release detailing the quarter’s results, along with related presentation materials posted to www.bd.com/investors, at approximately 6:00 a.m. Eastern Time (ET).

Spero Therapeutics, Inc announced that Pfizer Inc. has made a $40 million equity investment in Spero as part of the Pfizer Breakthrough Growth Initiative, a program focused on funding innovative science to meet patient needs.

Protagonist Therapeutics, Inc. reported that on June 30, 2021, it issued an inducement award to Patrick Smith, the Company’s recently hired Vice President, Quality Assurance, in accordance with the terms of Mr. Smith’s employment offer letter.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.

Amedisys, Inc., a leading home health, hospice and personal care company, announced that it has signed a definitive agreement to acquire Contessa Health, a leader in hospital-at-home and skilled nursing facility at-home services.